
Results 1 - 20 of 16,986 in Oncology
Research and Markets: Triple Analysis: Apoptosis, Angiogenesis and Cancer Vaccines
... criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different areas. The ... Comment?
More than skin deep: melanoma most often due to sun exposure
w/Photo
So we want to remind you to wear sunscreen as part of our year-long series "More Than Skin Deep." Skin cancer effects millions of people every year and some end up with more than one type of the disease. Comment?
Radioactive Nanoparticles Developed That Target Cancer Cells
... that target lymphoma tumor cells wherever they may be in the body. Michael Lewis, an associate professor of oncology in the MU College of Veterinary Medicine, says being able to target secondary tumors is vital to successfully treating patients with ... Comment?
Promising Early Results For Use Of Poliovirus Vaccine In Recurrent Glioblastoma
... tumor cells. Preliminary data, presented at the upcoming 2013 Annual Meeting of the American Society of Clinical Oncology in Chicago from May 31-June 4, 2013 (ASCO abstract #2094), previews the results of seven patients enrolled in the study whose ... Comment?
Sushiel Keswani, Executive Director, Ernst & Young LLP to Speak at...
... Hypoxic Respiratory Failure, Rheumatoid Arthritis, Urinary Incontinence, CV/Metabolics, Neuroscience, Virology and Oncology. Hel leads the Totality of HCP/O/A Spend and PPSA reporting related service offerings for EY in the US for all pharmaceutical ... Comment?
AllMed Helps Health Plan Nurses and Claims Managers Understand the...
... decisions and interventions for malignant cancers, are widely used as the standard for clinical policy in oncology by clinicians, utilization review and case management professionals. Dr. Webster explained that the NCCN recommendations are ... Comment?
Frequent Heartburn Increases Risk Of Throat Cancer By 78%
Main Category: Acid Reflux / GERD Also Included In: GastroIntestinal / Gastroenterology ; Cancer / Oncology ; Ear, Nose and Throat Article Date: 24 May 2013 - 0:00 PDT Frequent heartburn increases the risk of cancers of the throat and vocal cord among nondrinkers and nonsmokers, according to a new study. Comment?
SonaCare Medical highlights need for image-guided technologies to better identify prostate cancer
... with the Sonablate 500 as part of a UCL clinical trial led by Mark Emberton, MD, Professor of Interventional Oncology and Director of the Division of Surgery and Interventional Science at UCL. SonaCare recently announced a partnership with UCL ... Comment?
Takeda begins MLN9708 phase 3 clinical trial in newly diagnosed myeloma patients
... in the development of MLN9708, an oral proteasome inhibitor, and is a major achievement in advancing the Takeda Oncology pipeline," said Karen Ferrante, M.D, Head of the Takeda Oncology Therapeutic Unit. "The T O U R M AL INE-MM2 study is the first ... Comment?
... including First-in-Human (FIH), as well as specific therapeutic expertise in Allergy, Asthma, HCV, Ophthalmology, Oncology, Renal, and Vaccines. If you would like to request information about how WCCT Global can assist your organization with your ... Comment?
Spa To Pamper Cancer Patients
w/Photo
... part to help ease the pain. She aims to address one side effect of these life saving treatments by offering unique oncology spa treatments at her new business Skinchanted in Peekskill. "With chemo, the skin will change, can get itchy, get red and ... Comment?
Kantar Health Launches CancerMPact Biomarker Analysis
... of CancerMPact Biomarker Analysis , a global offer that examines biomarker segmentation in the current and evolving oncology landscape. The analysis is based on a thorough review of literature and recently published data covering the following ... Comment?
... wer your questions. Everyone is welcome to attend - patients, family and caregivers. No appointment needed. Tour of Oncology Treatment Center included. Questions? Call 919-613-6275. Comment?
Los Angeles plastic & reconstructive surgeons at La Peer Health Systems discuss the ramifications of Angelina Jolie's courageous choice to go public with her genetic issues with breast cancer. Comment?
Patient's plea: Let me move house
w/Photo
Location misery: Andrea Seymour, 52, and her daughter Emma, left, are worried Ms Seymour will not be approved for a property transfer by Housing New Zealand. Comment?
B.C. policy on ovarian cancer prevention gets international support
w/Photo
... ovarian cancer has been deemed safe by a new Italian study published Thursday in the medical journal Gynecologic Oncology. B.C. experts have been at the forefront of a change in surgical protocols that recommends the removal of women's Fallopian ... Comment?
Modified Polio Virus May Help Fight Brain Tumors, Study Suggests
w/Photo
... to overcome those problems." The findings are scheduled for presentation at the American Society of Clinical Oncology annual meeting in Chicago, from May 31 to June 4. Researchers at Duke said they developed the therapy to take advantage of the fact ... Comment?
Life goes on for young people in palliative care
Life goes on for young people who are diagnosed with cancer and are in palliative care, says Dr Rachel Hughes, who works in youth oncology services. Comment?
Sanofi Showcases Commitment to Prostate Cancer Research at Genitourinary Cancer Symposium
... Cancers Symposium in Orlando, FL. Major sponsors of the Symposium are the American Society of Clinical Oncology (ASCO), American Society of Radiation Oncology (ASTRO) and the Society of Urologic Oncology (SUO). Abstracts to be presented during ... Comment?
Celgene Announces U.S. FDA Grants Priority Review for ABRAXANEA sNDA in Advanced Pancreatic Cancer
... metastatic pancreatic cancer. Results from this study were recently presented at the American Society of Clinical Oncology's (ASCO) 2013 Gastrointestinal Cancers Symposium in January. Celgene is preparing a development plan for a phase III, ... Comment?